亚洲 · 区域市场 · CNBC-TV18
Piramal Pharma shares surge 14% as Q2 profitability improves, FY27 outlook raised
Following its strong first-half performance and sustained business momentum, Piramal Pharma upgraded its FY27 revenue growth outlook to 19%-20%. The company also expects…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
